These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32935208)

  • 1. Less intensive surveillance after radical surgery for stage I-III colorectal cancer by focusing on the doubling time of recurrence.
    Miyake H; Kawai K; Nozawa H; Sasaki K; Kaneko M; Murono K; Emoto S; Ishii H; Sonoda H; Ishihara S
    Surg Today; 2021 Apr; 51(4):550-560. PubMed ID: 32935208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial.
    Rodríguez-Moranta F; Saló J; Arcusa A; Boadas J; Piñol V; Bessa X; Batiste-Alentorn E; Lacy AM; Delgado S; Maurel J; Piqué JM; Castells A
    J Clin Oncol; 2006 Jan; 24(3):386-93. PubMed ID: 16365182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Surgical Resection on Metachronous Metastases of Colorectal Cancer According to Tumor Doubling Time.
    Miyake H; Murono K; Kawai K; Nozawa H; Maki H; Hasegawa K; Nakajima J; Ishihara S
    In Vivo; 2020; 34(6):3367-3374. PubMed ID: 33144444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
    Snyder RA; Hu CY; Cuddy A; Francescatti AB; Schumacher JR; Van Loon K; You YN; Kozower BD; Greenberg CC; Schrag D; Venook A; McKellar D; Winchester DP; Chang GJ;
    JAMA; 2018 May; 319(20):2104-2115. PubMed ID: 29800181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer.
    Miyake H; Murono K; Nagata H; Nozawa H; Kawai K; Hata K; Tanaka T; Nishikawa T; Shuno Y; Sasaki K; Ishihara S
    Int J Colorectal Dis; 2019 May; 34(5):801-809. PubMed ID: 30739186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-stratified intensive follow up for treated colorectal cancer - realistic and cost saving?
    Macafee DA; Whynes DK; Scholefield JH
    Colorectal Dis; 2008 Mar; 10(3):222-30. PubMed ID: 17645572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Surveillance Protocols After Curative Resection in Patients With Stage IV Colorectal Cancer: A Multicenter Retrospective Study.
    Kishiki T; Lapin B; Matsuoka H; Watanabe T; Takayasu K; Kojima K; Sugihara K; Masaki T
    Dis Colon Rectum; 2018 Jan; 61(1):51-57. PubMed ID: 29215480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracic recurrence in patients with curatively-resected colorectal cancer: incidence, risk factors, and value of chest CT as a postoperative surveillance tool.
    Lee JH; Park CM; Joo I; Suh YJ; Hwang EJ; Kim H; Goo JM
    Eur Radiol; 2019 Aug; 29(8):4303-4314. PubMed ID: 30350166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project.
    Hurle R; Lazzeri M; Vanni E; Lughezzani G; Buffi N; Casale P; Saita A; Morenghi E; Forni G; Cardone P; Lista G; Colombo P; Peschechera R; Pasini L; Zandegiacomo S; Benetti A; Maffei D; Vavassori I; Guazzoni G
    J Urol; 2018 Feb; 199(2):401-406. PubMed ID: 28847481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal of a stage-specific surveillance strategy for colorectal cancer patients: A retrospective analysis of Japanese large cohort.
    Okamura R; Hida K; Nishizaki D; Sugihara K; Sakai Y
    Eur J Surg Oncol; 2018 Apr; 44(4):449-455. PubMed ID: 29397263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial.
    Wille-Jørgensen P; Syk I; Smedh K; Laurberg S; Nielsen DT; Petersen SH; Renehan AG; Horváth-Puhó E; Påhlman L; Sørensen HT;
    JAMA; 2018 May; 319(20):2095-2103. PubMed ID: 29800179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is early surveillance with CT scan necessary in patients with stage II/III colorectal cancer: a retrospective study.
    Liu GC; Tang JH; Wen SJ; Cao HX; An X; Cai PQ; Kong LH; Lin JZ; Li LR; Pan ZZ; Ding PR
    J Surg Oncol; 2013 Dec; 108(8):568-71. PubMed ID: 24105780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and Recurrent Colorectal Cancers After Resection: a Systematic Review and Meta-analysis of Endoscopic Surveillance Studies.
    Fuccio L; Rex D; Ponchon T; Frazzoni L; Dinis-Ribeiro M; Bhandari P; Dekker E; Pellisè M; Correale L; van Hooft J; Jover R; Libanio D; Radaelli F; Alfieri S; Bazzoli F; Senore C; Regula J; Seufferlein T; Rösch T; Sharma P; Repici A; Hassan C
    Gastroenterology; 2019 Apr; 156(5):1309-1323.e3. PubMed ID: 30553914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical follow-up does not improve survival after resection of stage I-III colorectal cancer: A cohort study.
    Jones RP; McWhirter D; Fretwell VL; McAvoy A; Hardman JG
    Int J Surg; 2015 May; 17():67-71. PubMed ID: 25827817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttreatment Surveillance in Patients with Prolonged Disease-Free Survival After Resection of Colorectal Liver Metastasis.
    Galjart B; van der Stok EP; Rothbarth J; Grünhagen DJ; Verhoef C
    Ann Surg Oncol; 2016 Nov; 23(12):3999-4007. PubMed ID: 27393572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
    Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
    Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial.
    Secco GB; Fardelli R; Gianquinto D; Bonfante P; Baldi E; Ravera G; Derchi L; Ferraris R
    Eur J Surg Oncol; 2002 Jun; 28(4):418-23. PubMed ID: 12099653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection.
    Kim C; Kim WR; Kim KY; Chon HJ; Beom SH; Kim H; Jung M; Shin SJ; Kim NK; Ahn JB
    Clin Colorectal Cancer; 2018 Sep; 17(3):e513-e518. PubMed ID: 29661621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and fear of cancer recurrence in T1 colorectal cancer patients treated with endoscopic or surgical tumor resection.
    Dang H; de Vos Tot Nederveen Cappel WH; van der Zwaan SMS; van den Akker-van Marle ME; van Westreenen HL; Backes Y; Moons LMG; Holman FA; Peeters KCMJ; van der Kraan J; Langers AMJ; Lijfering WM; Hardwick JCH; Boonstra JJ
    Gastrointest Endosc; 2019 Mar; 89(3):533-544. PubMed ID: 30273589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to surveillance guidelines after curative resection for stage II/III colorectal cancer.
    Cheung WY; Pond GR; Rother M; Krzyzanowska MK; Swallow C; Brierley J; Kaizer L; Myers J; Hajra L; Siu LL
    Clin Colorectal Cancer; 2008 May; 7(3):191-6. PubMed ID: 18621637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.